Flynn Daniel Lee

Chief Scientific Officer at Deciphera Pharmaceuticals, Inc.

Sold, on record
$29M
Dollars the filings state
Form 4 sales
13
Latest Jun 16, 2023
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale Deciphera Pharmaceuticals, Inc.Unusual
    Dec 10, 2019 2019

    Sold 152,927 shares at $55.00 ($8.4M)

    Flynn Daniel Lee, Chief Scientific Officer

    Sold 86.2% of holdings ($9.8M position)24,500 shares left1x usual sizeFiling

  2. 2 Form 4 sale Deciphera Pharmaceuticals, Inc.Unusual
    Dec 12, 2019 +2 days

    Sold 31,029 shares at $60.00 ($1.9M)

    Flynn Daniel Lee, Chief Scientific Officer

    Sold 46.5% of holdings ($4M position)35,750 shares left0.2x usual sizeFiling

  3. 3 Form 4 sale Deciphera Pharmaceuticals, Inc.Plan not stated
    Feb 16, 2021 +432 days

    Sold 508 shares at $48.87 ($25k)

    Flynn Daniel Lee, Chief Scientific Officer

    Sold 7.2% of holdings ($344k position)6,532 shares left0x usual sizeFiling

  4. 4 Form 4 sale Deciphera Pharmaceuticals, Inc.Plan not stated
    Feb 16, 2022 +365 days

    Sold 1,366 shares at $9.05 ($12k)

    Flynn Daniel Lee, Chief Scientific Officer

    Sold 2.8% of holdings ($446k position)47,866 shares leftFiling

  5. 5 Form 4 sale Deciphera Pharmaceuticals, Inc.Plan not stated
    Jun 16, 2022 +120 days

    Sold 1,768 shares at $10.75 ($19k)

    Flynn Daniel Lee, Chief Scientific Officer

    Sold 3.7% of holdings ($515k position)46,098 shares leftFiling

  6. 6 Form 4 sale Deciphera Pharmaceuticals, Inc.Plan not stated
    Jan 17, 2023 +215 days

    Sold 2,403 shares at $21.24 ($51k)

    Flynn Daniel Lee, Chief Scientific Officer

    Sold 5.2% of holdings ($979k position)43,695 shares left1.8x usual sizeFiling

  7. 7 Form 4 sale Deciphera Pharmaceuticals, Inc.Plan not stated
    Feb 16, 2023 +30 days

    Sold 1,370 shares at $15.10 ($21k)

    Flynn Daniel Lee, Chief Scientific Officer

    Sold 2.3% of holdings ($909k position)58,813 shares left0.9x usual sizeFiling

  8. 8 Form 4 sale Deciphera Pharmaceuticals, Inc.No plan
    Jun 16, 2023 +120 days

    Sold 1,655 shares at $14.40 ($24k)

    Flynn Daniel Lee, Chief Scientific Officer

    No 10b5-1 planSold 2.8% of holdings ($847k position)57,158 shares left1.1x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (13)

Form 144 notices and Form 4 sales by Flynn Daniel Lee
Source
Jun 16, 2023Jun 21, 2023Deciphera Pharmaceuticals, Inc.Chief Scientific OfficerForm 4 sale1,655$24k2.8%No planSEC
Feb 16, 2023Feb 17, 2023Deciphera Pharmaceuticals, Inc.Chief Scientific OfficerForm 4 sale1,370$21k2.3%Plan not statedSEC
Jan 17, 2023Jan 19, 2023Deciphera Pharmaceuticals, Inc.Chief Scientific OfficerForm 4 sale2,403$51k5.2%Plan not statedSEC
Jun 16, 2022Jun 21, 2022Deciphera Pharmaceuticals, Inc.Chief Scientific OfficerForm 4 sale1,768$19k3.7%Plan not statedSEC
Feb 16, 2022Feb 18, 2022Deciphera Pharmaceuticals, Inc.Chief Scientific OfficerForm 4 sale1,366$12k2.8%Plan not statedSEC
Feb 16, 2021Feb 18, 2021Deciphera Pharmaceuticals, Inc.Chief Scientific OfficerForm 4 sale508$25k7.2%Plan not statedSEC
Dec 12, 2019Dec 13, 2019Deciphera Pharmaceuticals, Inc.Chief Scientific OfficerForm 4 sale31,029$1.9M46.5%UnusualSEC
Dec 10, 2019Dec 11, 2019Deciphera Pharmaceuticals, Inc.Chief Scientific OfficerForm 4 sale152,927$8.4M86.2%UnusualSEC
Nov 11, 2019Nov 13, 2019Deciphera Pharmaceuticals, Inc.Chief Scientific OfficerForm 4 sale152,927$7.3M86.2%UnusualSEC
Oct 28, 2019Oct 30, 2019Deciphera Pharmaceuticals, Inc.Chief Scientific OfficerForm 4 sale29,820$1.2M54.9%UnusualSEC
Aug 13, 2019Aug 13, 2019Deciphera Pharmaceuticals, Inc.Chief Scientific OfficerForm 4 sale148,107$6.1M85.8%UnusualSEC
Jan 16, 2019Jan 18, 2019Deciphera Pharmaceuticals, Inc.Chief Scientific OfficerForm 4 sale152,629$4M100.0%UnusualSEC
Jan 11, 2019Jan 15, 2019Deciphera Pharmaceuticals, Inc.Chief Scientific OfficerForm 4 sale300$8k100.0%UnusualSEC